Skip to main content

Gemini DRC A Prospective Natural History Study to Evaluate Clinical Characteristics and Disease Progression in Subjects with Non-central Geographic Atrophy (GA) Who Are Carriers of High-risk Genetic Variants of Complement Factor H (CFH)

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Gemini Therapeutics

Start Date

October 10, 2018

End Date

October 18, 2022
 

Administered By

Ophthalmology

Awarded By

Gemini Therapeutics

Start Date

October 10, 2018

End Date

October 18, 2022